CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Profit Margin (Quarterly): -73.51K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -73.51K% |
September 30, 2023 | |
June 30, 2023 | -2.61% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 |
Date | Value |
---|---|
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | -96.85% |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | -111.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-73.51K%
Minimum
Dec 2023
-2.61%
Maximum
Jun 2023
-36.76K%
Average
-36.76K%
Median
Profit Margin (Quarterly) Benchmarks
Gilead Sciences Inc | -62.37% |
Assure Holdings Corp | -31.25K% |
Societal CDMO Inc (DELISTED) | -2.84% |
AN2 Therapeutics Inc | -- |
Madrigal Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -60.75% |
Return on Assets | -35.13% |
Return on Invested Capital | -38.61% |
Operating Margin (Quarterly) | -74.56K% |
Return on Net Operating Assets | -5.27K% |